Home World News FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for... World News FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 238 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR How can we improve LGBTQ+ cancer care? – That Cancer Conversation June 27, 2023 Some Brain Cells May Help to Fuel Cancer Metastasis November 21, 2019 Vorasidenib Treatment Shows Promise for Some Low-Grade Gliomas June 27, 2023 Medicare Open Enrollment is Almost Here-What You Need to Know for... October 13, 2020 Load more HOT NEWS Increased Risk of Haematologic Malignancies Among Children and Adolescents Exposed to... Her Massive Weight Loss Helped Her Feel A Lump In Her... OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally... Prescribing Exercise as Cancer Treatment: A Conversation with Dr. Kathryn Schmitz